These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26188238)

  • 1. Intractable hypoglycaemia in a patient with advanced carcinoid syndrome successfully treated with hepatic embolization.
    Kyriacou A; Mansoor W; Lawrance J; Trainer PJ
    Hormones (Athens); 2016; 15(1):118-21. PubMed ID: 26188238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prompt resolution of hypoglycemia by hepatic transarterial embolization for malignant insulinoma with multiple liver metastases.
    Muro S; Nasu J; Harada R; Matsubara M; Nakarai A; Kanzaki H; Tsutsumi K; Kato H; Tanaka T; Fujiwara H; Uno M; Okada H; Yamamoto K
    Acta Med Okayama; 2014; 68(5):303-6. PubMed ID: 25338488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment: symptomatic treatment of hypoglycaemia.
    Tabarin A; Goichot B;
    Ann Endocrinol (Paris); 2013 Jul; 74(3):196-9. PubMed ID: 23791453
    [No Abstract]   [Full Text] [Related]  

  • 4. Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors.
    Strosberg JR; Choi J; Cantor AB; Kvols LK
    Cancer Control; 2006 Jan; 13(1):72-8. PubMed ID: 16508629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of refractory hypoglycaemia in a metastatic neuroendocrine tumour co-secreting serotonin and insulin.
    Bhullar JS; Leung JM; Almehthel MS
    BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33168531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug therapy for neuroendocrine tumours].
    Tóth M
    Orv Hetil; 2013 Sep; 154(39):1556-64. PubMed ID: 24058101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Everolimus plus octreotide long-acting repeatable in advanced neuroendocrine tumors in the routine tertiary cancer care setting: An Indian experience.
    Tippeswamy R; Patil S; Sateesh CT; Shashidhara HP; Prabhudesai S; Prashanth P; Haridas KM
    Indian J Cancer; 2015; 52(3):359-62. PubMed ID: 26905137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapies for the medical management of persistent hypoglycaemia in two cases of inoperable malignant insulinoma.
    Ong GS; Henley DE; Hurley D; Turner JH; Claringbold PG; Fegan PG
    Eur J Endocrinol; 2010 May; 162(5):1001-8. PubMed ID: 20164213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study.
    Pavel ME; Hainsworth JD; Baudin E; Peeters M; Hörsch D; Winkler RE; Klimovsky J; Lebwohl D; Jehl V; Wolin EM; Öberg K; Van Cutsem E; Yao JC;
    Lancet; 2011 Dec; 378(9808):2005-2012. PubMed ID: 22119496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Previous Somatostatin Analogue Use on the Activity of Everolimus in Patients with Advanced Neuroendocrine Tumors: Analysis from the Phase III RADIANT-2 Trial.
    Anthony LB; Pavel ME; Hainsworth JD; Kvols LK; Segal S; Hörsch D; Van Cutsem E; Öberg K; Yao JC
    Neuroendocrinology; 2015; 102(1-2):18-25. PubMed ID: 25824001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoid crisis 24 hours after bland embolization: A case report.
    Fujie S; Zhou W; Fann P; Yen Y
    Biosci Trends; 2010 Jun; 4(3):143-4. PubMed ID: 20592464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic cytoreduction followed by a novel long-acting somatostatin analog: a paradigm for intractable neuroendocrine tumors metastatic to the liver.
    Chung MH; Pisegna J; Spirt M; Giuliano AE; Ye W; Ramming KP; Bilchik AJ
    Surgery; 2001 Dec; 130(6):954-62. PubMed ID: 11742323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of gastroentero-pancreatic neuroendocrine tumors (GEP-NETs).
    Desai KK; Khan MS; Toumpanakis C; Caplin ME
    Minerva Gastroenterol Dietol; 2009 Dec; 55(4):425-43. PubMed ID: 19942827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic considerations for the malignant carcinoid syndrome.
    Kvols LK
    Acta Oncol; 1989; 28(3):433-8. PubMed ID: 2663050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New and Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors.
    Phan AT; Kunz PL; Reidy-Lagunes DL
    Clin Adv Hematol Oncol; 2015 May; 13(5 Suppl 5):1-18; quiz 1 p following 18. PubMed ID: 26430956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with somatostatin analogs and chemoembolization of liver metastases for severe hypoglycemia in malignant insulinomas.
    Maiza JC; Vezzosi D; Grunenwald S; Otal P; Guimbaud R; Bennet A; Caron P
    J Endocrinol Invest; 2011 Oct; 34(9):e253-8. PubMed ID: 21623151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid reversal of life-threatening hypoglycaemia with a somatostatin analogue (octreotide). A case report.
    Alberts AS; Falkson G
    S Afr Med J; 1988 Jul; 74(2):75-6. PubMed ID: 2899913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Everolimus Related Fulminant Hepatitis in Pancreatic Neuroendocrine Tumor With Liver Metastases: A Case Report and Literature Review.
    Chang SC; Tsai CY; Liu KH; Wang SY; Hsu JT; Yeh TS; Yeh CN
    Front Endocrinol (Lausanne); 2021; 12():639967. PubMed ID: 33868173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic artery embolization in the treatment of intractable hypoglycaemia.
    Wells JL; Heath DA; West RJ
    J R Soc Med; 1990 Sep; 83(9):592-3. PubMed ID: 2213813
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of metastatic carcinoid with the somatostatin analog octreotide and with recombinant interferon alfa 2b].
    Linkesch M; Kuzmits R; Geyer G
    Wien Klin Wochenschr; 1989 Jun; 101(13):455-7. PubMed ID: 2763566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.